DuPont Files Q3 2024 10-Q Report
Ticker: DD · Form: 10-Q · Filed: Nov 5, 2024 · CIK: 1666700
| Field | Detail |
|---|---|
| Company | Dupont De Nemours, Inc. (DD) |
| Form Type | 10-Q |
| Filed Date | Nov 5, 2024 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.01, $1 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, SEC filing
TL;DR
DuPont's Q3 2024 10-Q is in. Check financials.
AI Summary
DuPont de Nemours, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key financial data and business operations for this period are detailed within the report.
Why It Matters
This report provides investors with crucial financial performance data for DuPont, impacting investment decisions and market sentiment.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal significant risks or opportunities.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter and year-to-date period covered by the report.)
- 2024-11-05 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- DuPont de Nemours, Inc. (company) — Filer of the 10-Q report
- 2024-09-30 (date) — End of the reporting period
- 2024-11-05 (date) — Date the filing was made
- DowDuPont Inc. (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the period ending September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 5, 2024.
What was DuPont de Nemours, Inc.'s former company name?
DuPont de Nemours, Inc.'s former company name was DowDuPont Inc.
What is the fiscal year end for DuPont de Nemours, Inc.?
The fiscal year end for DuPont de Nemours, Inc. is December 31.
In which state was DuPont de Nemours, Inc. incorporated?
DuPont de Nemours, Inc. was incorporated in Delaware (DE).
Filing Stats: 4,796 words · 19 min read · ~16 pages · Grade level 18.6 · Accepted 2024-11-05 10:01:12
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share DD New York Stock Exchange
- $1 billion — realize the anticipated benefits of the $1 billion share repurchase program announced on F
Filing Documents
- dd-20240930.htm (10-Q) — 1939KB
- exhibit311093024.htm (EX-31.1) — 11KB
- exhibit312093024.htm (EX-31.2) — 11KB
- exhibit313093024.htm (EX-31.3) — 11KB
- exhibit321093024.htm (EX-32.1) — 5KB
- exhibit322093024.htm (EX-32.2) — 5KB
- exhibit323093024.htm (EX-32.3) — 5KB
- 0001666700-24-000036.txt ( ) — 11818KB
- dd-20240930.xsd (EX-101.SCH) — 78KB
- dd-20240930_cal.xml (EX-101.CAL) — 138KB
- dd-20240930_def.xml (EX-101.DEF) — 414KB
- dd-20240930_lab.xml (EX-101.LAB) — 897KB
- dd-20240930_pre.xml (EX-101.PRE) — 676KB
- dd-20240930_htm.xml (XML) — 2058KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION PAGE
Consolidated Financial Statements (Unaudited)
Item 1. Consolidated Financial Statements (Unaudited) Consolidated Statements of Operations 6 Consolidated Statements of Comprehensive Income 7 Condensed Consolidated Balance Sheets 8 Consolidated Statements of Cash Flows 9 Consolidated Statements of Equity 10 Notes to the Consolidated Financial Statements (Unaudited) 12
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 43 Overview 43 Results of Operations 45 Segment Results 48 Changes in Financial Condition 52
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 56
Controls and Procedures
Item 4. Controls and Procedures 56
- OTHER INFORMATION
PART II - OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 57
Risk Factors
Item 1A. Risk Factors 58
Unregistered Sales of Equity Securities, Use of Proceeds and Purchases of Equity Securities
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Purchases of Equity Securities 60
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 60
Other Information
Item 5. Other Information 60
Exhibits
Item 6. Exhibits 61
SIGNATURES
SIGNATURES 62 3 Table of Contents DuPont de Nemours, Inc. DuPont TM and all products, unless otherwise noted, denoted with TM , SM or are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc. Overview On May 22, 2024, DuPont announced a plan to separate the company into three distinct, publicly traded companies, ("Intended Business Separations"). Under the plan, DuPont would execute the proposed separations of its Electronics and Water businesses in a tax-free manner to its shareholders leaving DuPont to continue as a diversified industrial company following completion of the separations. DuPont expects to complete the separations within 18 to 24 months of the announcement date. The separation transactions will not require a shareholder vote and are subject to satisfaction of customary conditions, including final approval by DuPont's Board of Directors, receipt of tax opinion from counsel, the filing and effectiveness of Form 10 registration statements with the U.S. Securities and Exchange Commission, applicable regulatory approvals and satisfactory completion of financing. Please refer to the announcement and presentation materials from May 22, 2024, posted to the Investor section of www.dupont.com, for more information. Effective as of January 1, 2024, Electronics & Industrial realigned certain product lines that comprise its business units (Industrial Solutions, Interconnect Solutions and Semiconductor Technologies) that are intended to optimize business operations across the segment leading to enhanced value for customers and cost savings. The Net Trade Revenue by Segment and Business or Major Product Line has been recast for all periods presented to reflect the new structure. The realignment did not result in changes to total Electronics and Industrial segment net sales. On November 1, 2023, DuPont completed the divestiture of the Delrin acetal homopolymer (H-POM) business to TJC LP, (the "Delrin Divestiture
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This document contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the ability of DuPont to effect the separation transactions described above and to meet the conditions related thereto; (ii) the possibility that the separation transactions will not be completed within the anticipated time period or at all; (iii) the possibility that the separation transactions will not achieve their intended benefits; (iv) the impact of the separation transactions on DuPont's businesses and the risk that the separations may be more difficult, time-consuming or costly than expected, including the impact on DuPont's resources, systems, procedures and controls, diversion of management's attention and the impact
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS DuPont de Nemours, Inc. Consolidated Statements of Operations Three Months Ended September 30, Nine Months Ended September 30, In millions, except per share amounts (Unaudited) 2024 2023 2024 2023 Net sales $ 3,192 $ 3,058 $ 9,294 $ 9,170 Cost of sales 1,998 1,954 5,912 5,967 Research and development expenses 134 128 393 380 Selling, general and administrative expenses 387 360 1,189 1,058 Amortization of intangibles 149 155 449 448 Restructuring and asset related charges - net 21 8 68 39 Acquisition, integration and separation costs 43 9 51 15 Equity in earnings of nonconsolidated affiliates 14 11 49 40 Sundry income (expense) - net 199 55 150 112 Interest expense 87 102 282 295 Income from continuing operations before income taxes $ 586 $ 408 $ 1,149 $ 1,120 Provision for income taxes on continuing operations 106 117 310 287 Income from continuing operations, net of tax $ 480 $ 291 $ 839 $ 833 (Loss) income from discontinued operations, net of tax ( 18 ) 37 5 ( 357 ) Net income $ 462 $ 328 $ 844 $ 476 Net income attributable to noncontrolling interests 8 9 23 31 Net income available for DuPont common stockholders $ 454 $ 319 $ 821 $ 445 Per common share data: Earnings per common share from continuing operations - basic $ 1.13 $ 0.62 $ 1.95 $ 1.76 (Loss) earnings per common share from discontinued operations - basic ( 0.04 ) 0.08 0.01 ( 0.78 ) Earnings per common share - basic $ 1.09 $ 0.71 $ 1.96 $ 0.97 Earnings per common share from continuing operations - diluted $ 1.13 $ 0.62 $ 1.94 $ 1.75 (Loss) earnings per common share from discontinued operations - diluted ( 0.04 ) 0.08 0.01 ( 0.78 ) Earnings per common share - diluted $ 1.08 $ 0.70 $ 1.95 $ 0.97 Weighted-average common shares outstanding - basic 417.9 451.7 419.5 456.5 Weighted-average common shares outstanding - diluted 419.5 453.4 420.8 457.8 See Notes to the Consolidated Financial Statements. 6 DuPont de Nemours, Inc. Consolidated Sta